The effects of a selective inhibitor of c-Fos/activator protein-1 on endotoxin-induced acute kidney injury in mice

BMC Nephrology

Nobuhiro Maekawa¹  Shunichi Shiozawa²  Kahoru Nishina¹  Masaaki Ueki¹  Jun Morishita¹  Hiroyuki Miyazaki¹ 

[1] Division of Anesthesiology and Perioperative Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Hyogo, 650-0017, Japan;Department of Medicine, Kyushu University Beppu Hospital, 4546 Tsurumihara, Beppu, Oita, 874-0838, Japan

关键词: Activator protein-1;    Lipopolysaccharide;    TNF-α;    Acute kidney injury;    Sepsis;   

Others  :  1083058
DOI  :  10.1186/1471-2369-13-153

 received in 2012-07-26, accepted in 2012-11-18,  发布年份 2012

【 摘 要 】

Background

Sepsis has been identified as the most common cause of acute kidney injury (AKI) in intensive care units. Lipopolysaccharide (LPS) induces the production of several proinflammatory cytokines including tumor necrosis factor (TNF)-alpha, a major pathogenetic factor in septic AKI. c-Fos/activator protein (AP)-1 controls the expression of these cytokines by binding directly to AP-1 motifs in the cytokine promoter regions. T-5224 is a new drug developed by computer-aided drug design that selectively inhibits c-Fos/AP-1 binding to DNA. In this study, we tested whether T-5224 has a potential inhibitory effect against LPS-induced AKI, by suppressing the TNF-alpha inflammatory response and other downstream effectors.

Methods

To test this hypothesis, male C57BL/6 mice at 7 weeks old were divided into three groups (control, LPS and T-5224 groups). Mice in the control group received saline intraperitoneally and polyvinylpyrrolidone solution orally. Mice in the LPS group were injected intraperitoneally with a 6 mg/kg dose of LPS and were given polyvinylpyrrolidone solution immediately after LPS injection. In the T-5224 group, mice were administered T-5224 orally at a dose of 300 mg/kg immediately after LPS injection. Serum concentrations of TNF-alpha, interleukin (IL)-1beta, IL-6 and IL-10 were measured by ELISA. Moreover, the expression of intercellular adhesion molecule (ICAM)-1 mRNA in kidney was examined by quantitative real-time RT-PCR. Finally, we evaluated renal histological changes.

Results

LPS injection induced high serum levels of TNF-alpha, IL-1beta and IL-6. However, the administration of T-5224 inhibited the LPS-induced increase in these cytokine levels. The serum levels of IL-10 in the LPS group and T-5224 group were markedly elevated compared with the control group. T-5224 also inhibited LPS-induced ICAM-1 mRNA expression. Furthermore histological studies supported an anti-inflammatory role of T-5224.

Conclusions

In endotoxin-induced AKI, T-5224 inhibited the production of TNF-alpha and other downstream effectors. In contrast, T-5224 did not inhibit IL-10, an anti-inflammatory cytokine. These data support that the use of T-5224 is a promising new treatment for septic kidney injury.

【 授权许可】

   
2012 Miyazaki et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004, 351:159-169.
• [2]Danese S, Dejana E, Fiocchi C: Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 2007, 178:6017-6022.
• [3]Riedemann NC, Guo RF, Ward PA: The enigma of sepsis. J Clin Invest 2003, 112:460-467.
• [4]Whitmarsh AJ, Davis RJ: Transcription factor AP-1 regulation by mitogen- activated protein kinase signal transduction pathways. J Mol Med 1996, 74:589-607.
• [5]Aikawa Y, Morimoto K, Yamamoto T, Chaki H, Hashiramoto A, Narita H, Hirono S, Shiozawa S: Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat Biotechnol 2008, 26:817-823.
• [6]Wu X, Guo R, Wang Y, Cunningham PN: The role of ICAM-1 in endotoxin-induced acute renal failure. Am J Physiol Renal Physiol 2007, 293:F1262-1271.
• [7]Goes N, Urmson J, Ramassar V, Halloran PF: Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995, 59:565-572.
• [8]Schrier RW: Cancer therapy and renal injury. J Clin Invest 2002, 110:743-745.
• [9]Daemen MA, van de Ven MW, Heineman E, Buurman WA: Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation 1999, 67:792-800.
• [10]Ramesh G, Reeves WB: TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002, 110:835-842.
• [11]Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002, 168:5817-5823.
• [12]Hambleton J, Weinstein SL, Lem L, DeFranco AL: Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci U S A 1996, 93:2774-2778.
• [13]Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990, 348:550-552.
• [14]Chawla LS, Seneff MG, Nelson DR, Williams M, Levy H, Kimmel PL, Macias WL: Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis. Clin J Am Soc Nephrol 2007, 2:22-30.
• [15]Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999, 27:1230-1251.
• [16]Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
• [17]Hirata N, Yanagawa Y, Ogura H, Satoh M, Noguchi M, Matsumoto M, Togashi H, Onoe K, Iwabuchi K: The role of tumor necrosis factor-α for interleukin-10 production by murine dendritic cells. Cell Immunol 2011, 266:165-171.
• [18]Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF: Neutrophils in development of multiple organ failure in sepsis. Lancet 2006, 368:157-169.
• [19]Myers CL, Wertheimer SJ, Schembri-King J, Parks T, Wallace RW: Induction of ICAM-1 by TNF-alpha, IL-1 beta and LPS in human endothelial cells after downregulation of PKC. Am J Physiol 1992, 263:C767-772.
• [20]Cunningham PN, Michael Holers V, Alexander JJ, Guthridge JM, Carroll MC, Quigg RJ: Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure. Kidney Int 2000, 58:1580-7.
• [21]Baldwin AS Jr: The NF-κB and I-κB proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683.